| AD | Alzheimer’s disease |
| AGEs | Advanced glycation end-product |
| AICD | Amyloid precursor protein intracellular domain |
| ALS | Amyotrophic lateral sclerosis |
| ANP | Atrial natriuretic peptide |
| APP | Amyloid precursor protein |
| Asn | Asparagine |
| Aβ | Amyloid beta |
| BACE-1 | β-Site APP-cleaving enzyme 1 |
| CAG | Glutamine-coding |
| CCI4 | Carbon tetrachloride |
| CMD | Congenital muscular dystrophy |
| CML | N-carboxymethyl-lysine |
| CN | Caudate nucleus |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| CSF | Cerebrospinal fluid |
| CTF | C-terminal fragments |
| CTLA-4 | Cytotoxic T lymphocyte antigen 4 |
| dolichol-P | Dolichol-phosphate |
| DON | 6-Diazo-5-oxo-L-norleucine |
| ECM | Extracellular matrix |
| ELISA | Enzyme-linked immunosorbent assay |
| ER | Endoplasmic reticulum |
| ERAD | ER-associated degradation |
| ErkFDA | Extracellular signal-regulated kinasesFood and Drug Administration |
| GlcNAc | N-acetylglucosamine |
| GlcNAc-1-P | N-acetylglucosamine-1-phosphate |
| GlcNAc6ST1 | A carbohydrate sulfotransferase |
| GM1 | Monosialotetrahexosylganglioside |
| GM2 | Monosialic ganglioside |
| GM3 | Monosialodihexosylganglioside |
| GSLs | Glycosphingolipids |
| HD | Huntington’s disease |
| HMGB1 | High mobility group box 1 protein |
| HNK-1 | Human natural killer-1 glycan antigen |
| HSAS | X-linked hydrocephalus with stenosis of the aqueduct of sylvius |
| I-R | Ischemia–reperfusion |
| IgG | Immunoglobulin G |
| IL-6 | Interleukin 6 |
| L-DOPA | Levodopa |
| L1CAM | Neural cell adhesion molecule L1 |
| LacCer | Lactosylceramide |
| Lewy bodies | α-Synuclein aggregates |
| LeX | LewisX |
| LIGA-20 | A blood–brain barrier-permeable GM1 analogue |
| MALDI-TOF | Matrix-assisted Laser Desorption/Ionization |
| MASA syndrome | A rare X-linked recessive neurological disorder on the L1 disorder spectrum |
| MEB | Muscle–eye–brain disease |
| mHtt | Mutant huntingtin |
| MS | Multiple Sclerosis |
| NCAM | Neural cell adhesion molecule |
| NeuGc | N-glycolylneuraminic acid |
| NF-kβ | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | Nitric oxide |
| NSPC | Neural stem and progenitor cells |
| NTD | Neural tube defect |
| O-GlcNAc | O-linked β-N-acetylglucosamine |
| OGA | O-GlcNAcase |
| OGT | O-GlcNAc transferase |
| P0 | Myelin protein zero |
| p3 peptide | 3-kDa fragments of amino-terminal truncated Aβ peptides |
| PD | Parkinson’s disease |
| PHFs | Paired helical filaments |
| PNS | Peripheral nervous system |
| pRb | Etinoblastoma protein |
| PS | Presenilin |
| PSA | Polysialic acid |
| PST | ST8Sia IV |
| PTM | Post-translational modification |
| RAGE | Receptor for advanced glycation end-products |
| ROS | Reactive oxygen species |
| Ser | Serine |
| Sirt1 | NAD-dependent deacetylase sirtuin-1 |
| sLeX | Sialyl LewisX |
| SOD1 | Superoxide dismutase 1 |
| sRAGE | Soluble receptor for advanced glycation end-products |
| ST | Sialyltransferase |
| STAT3 | Signal transducer and activator of transcription 3 |
| STX | ST8Sia II |
| Thr | Threonine |
| TNF-α | Tumor necrosis factor alpha |
| UA | Ursolic acid |
| UDP | Uridine diphosphate |
| α-Sp22 | A glycosylated form of α-synuclein |